Predictors & Mechanisms of Adolescent PTSD
Identifying Biobehavioral Predictors and Targeting Mechanisms of Intervention in Adolescent Posttraumatic Stress Disorder
2 other identifiers
interventional
180
1 country
1
Brief Summary
This study examines how adolescents with trauma-related symptoms respond to stress and strong emotions. The study assesses brain activity, physiological responses, and behavior during experimental tasks that involve responding to potential threats, regulating emotions, and repeatedly imagining details of a personally experienced stressful or traumatic event using a script-driven imagery task. The study evaluates whether repeated imaginal exposure is associated with changes in anxiety and physiological responses across sessions, and whether baseline patterns of threat reactivity and emotion regulation are associated with individual differences in response to the exposure task. Outcomes include self-reported anxiety, subjective distress ratings, and psychophysiological indices such as heart rate, skin conductance, and electromyographic activity. The goal of this research is to improve understanding of biobehavioral processes related to trauma exposure in adolescents and to identify potential predictors of response to exposure-based intervention components relevant to posttraumatic stress disorder (PTSD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Apr 2026
Longer than P75 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2031
April 17, 2026
April 1, 2026
4.9 years
March 30, 2026
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
State Anxiety (State and Trait Anxiety Inventory for Children - State Scale)
Baseline (Visit 1, prior to first script-driven imagery task) and 1 week after baseline (Visit 2, following repeated imaginal exposure)
Corrugator Supercilii Electromyography (EMG) Reactivity
During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)
Heart Rate Reactivity During Script-Driven Imagery
During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)
Skin Conductance Reactivity During Script-Driven Imagery
During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)
Posttraumatic Stress Disorder Symptoms (UCLA PTSD Reaction Index for DSM-5)
Baseline (Visit 1) and 1 month after baseline (Visit 3)
Secondary Outcomes (1)
Subjective units of distress (SUDS)
Visit 1 (baseline) to Visit 2 (1 week)
Study Arms (1)
Exposure Arm
EXPERIMENTALInterventions
Repeated administration (5 repetitions) of a script including details of the individual's exposure to a traumatic event.
Eligibility Criteria
You may qualify if:
- Adolescent of any sex, race, or ethnicity; between the ages of 14 and 18 years old.
- Accompaniment by a caregiver willing to participate. Note: Adolescents aged 18 years old are able to provide their own consent though still require caregiver participation to be eligible for study participation.
- Ability to comprehend English. Rationale: Public census data indicates that the overwhelming majority of youth in the local community are English-speaking (\>98%), inclusive of multi-lingual households.
- Endorsement of exposure to one or more potentially traumatic event(s), as defined by DSM-5 Criterion A event, that the adolescent remembers and is able to verbalize.
- A total score ≥15 on the Child and Adolescent Trauma Screen (CATS) or report at least one clinically significant symptom on Intrusion/Re-experiencing, Avoidance, and Hyperarousal symptom domains, as defined by DSM-5 PTSD criteria, and one area of impairment.
You may not qualify if:
- Previous diagnosis indicating intellectual disability or pervasive developmental disorder that would preclude participant from understanding study procedures.
- Active psychosis, bipolar disorder, or a comorbid condition that requires a higher level of immediate care (e.g., anorexia nervosa, alcohol withdrawal).
- Active suicide risk with ideation, plan and intent and/or recent (past 6 months) hospitalization for suicidality. These individuals will be referred directly for immediate services and treatment. All participants who endorse suicidal ideation will be engaged in safety planning as part of the study protocol.
- Individuals on psychotropic medications must be stabilized on the medication for at least four weeks prior to study start date.
- Individuals currently engaged in trauma-focused, exposure-based treatment.
- Caregiver, parent, or legal guardian of an adolescent between the ages of 14 and 18 years old.
- Ability to comprehend English.
- \. Previous diagnosis indicating intellectual disability or pervasive developmental disorder that would preclude participant from understanding study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2026
First Posted
April 17, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
March 1, 2031
Study Completion (Estimated)
March 1, 2031
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data from the K23 study will be made available to other researchers upon request after the completion of the K23 major aims papers, and available for 5 years after that date.
- Access Criteria
- Data from the K23 study will be made available to other researchers upon written request stating the investigators names, affiliated institution, and proposed specific research question. Investigators should submit a conflict of interest statement. To gain access to the data, the investigator making the request must provide: (1) agreement to use data only for research purposes; (2) a commitment not to identify any individual participant (information will be de-identified); (3) a promise to secure the data according to NIMH, institutional, and IRB guidelines to ensure data safety and participant confidentiality; and (4) a commitment to destroy or return the data after the specified analyses are completed.
A de-identified data set will use unique identifier numbers that are not related to any personal identifying information. After the completion of the K23 major aims papers, data from the K23 study will be made available to other researchers upon request. A written request should state the investigators names, affiliated institution, and proposed specific research question. Investigators should also submit a conflict of interest statement. To gain access to the data, the investigator making the request must provide: (1) agreement to use data only for research purposes; (2) a commitment not to identify any individual participant (information will be de-identified); (3) a promise to secure the data according to NIMH, institutional, and IRB guidelines to ensure data safety and participant confidentiality; and (4) a commitment to destroy or return the data after the specified analyses are completed. All data sharing will follow the guidelines and rules of the NIH and IRB.